Busulfan and cyclophosphamide (BuCy) are currently the most widely used myeloablative regimen to treat malignancies with allogeneic stem cell transplantation. Fludarabine has considerable efficacy in ...

Please provide your email address to receive an email when new articles are posted on . The regimen appeared associated with low rates of severe acute GVHD, chronic GVHD and nonrelapse mortality, as ...

High dose busulfan is widely used in preparative regimens for bone marrow transplantation. We describe three cases of accidental busulfan overdosing. Two adults received a single dose of 8 and 18 ...

Please provide your email address to receive an email when new articles are posted on . Patients with acute myelogenous leukemia in first remission treated with cyclophosphamide plus busulfan ...

Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials We performed an open-label, randomized ...

HOUSTON — Using a treosulfan-based myeloablative regimen in place of one based on busulfan may improve survival in vulnerable patients with acute myeloid leukemia (AML) and myelodysplastic syndrome ...

Therapeutic drug monitoring (TDM) of Busulfan is essential for management of Bone Marrow Transplant (BMT) patients, by optimizing dose, supporting compliance, and minimizing toxicity. Busulfan is a ...

Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil. Fourteen patients remain in first remission 18 to 60 months posttransplant. Five patients ...

It remains controversial whether busulfan-based versus total body irradiation (TBI)–based regimens have comparable outcomes in patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic ...

Details concerning the Busulfan (2mg) medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...